A Case Report of Quinine-Induced Thrombotic Microangiopathy Successfully Treated With Eculizumab
Drug-induced thrombotic microangiopathy (DITMA) is a life-threatening condition which may be immune or nonimmune mediated. Quinine is the most implicated drug in immune-mediated DITMA. However, the optimal treatment is unclear. Complement inhibition by eculizumab has demonstrated success in many DIT...
Saved in:
Main Authors: | Jun Yen Ng BMedSci (Hons) (Author), Douglas Lenton MBBS, FRACP, FRCPA (Author), Ian Kerridge BA, BMed (Hons) (Author), Charmaine Wong MBBS, FRACP, FRCPA (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy
by: Jihad Ben Gabr MD, et al.
Published: (2020) -
Dermatomyositis Associated With High-Grade B-Lymphoproliferative Disorders: A Case Report and Literature Review
by: Jun Yen Ng MBBS, et al.
Published: (2024) -
The importance of dermoscopy in subclinical lichen planus in skin of color
by: In Young Chung, MBBS (Hons), et al.
Published: (2021) -
Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report
by: Mihriban İnözü, et al.
Published: (2022) -
Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy
by: Laura Gomez-Ganda, et al.
Published: (2021)